Medifast outlines Q4 2025 revenue guidance of $65M–$80M amid strategic shift to metabolic health solutions
Medifast outlines Q4 2025 revenue guidance of $65M–$80M amid strategic shift to metabolic health solutions Source link
Vertex falls despite Q3 double beats as 2025 revenue guidance narrowed
Vertex falls despite Q3 double beats as 2025 revenue guidance narrowed Source link
SUI Token Drops 9% as Institutional Selling Hits Harder Than Broader Crypto Market
SUI, the native token of the Sui network, plunged 9% to $2.10 over the past 24 hours, sharply underperforming the…
Godfrey Phillips Q2 Results: Profit rises 23% to Rs 305 crore
Cigarette maker Godfrey Phillips India on Monday reported an increase of 22.8 per cent in consolidated net profit at Rs…
Acquires Crypto Wallet Firm to Expand Institutional Payments Business
Ripple, the blockchain tech firm closely associated with the XRP Ledger (XRP) network, said on Monday it has acquired crypto…
Revolution Medicines a new outperform at RBC on RAS(ON) inhibitors for cancers
alexsl RBC Capital Markets has initiated Revolution Medicines (RVMD) at outperform, saying that its platform of “RAS(ON)” inhibitors to treat…
How to calculate market cap to sales ratio and what it means
The market cap to sales ratio reveals how much investors pay for each rupee of a company’s sales, helping assess…
InterGlobe Aviation Q2 preview: Brokerages split on earnings, see up to 13% YoY revenue rise
InterGlobe Aviation will announce its September quarter earnings on Tuesday, November 4, where the IndiGo operator is expected to report…
Stellar Holds the Line at $0.277 as Buyers Defend Key Support Zone
Stellar (XLM) bounced to $0.285 on Tuesday following a sell-off, with trading volumes running 11.18% above the 30-day average as…
Tata Consumer says GST rate cut transition hit sales of key brands
FMCG firm Tata Consumer Products managing director Sunil D’Souza on Monday said three of its brands — Capital Foods, Organic…